← Eichor
Condition: Covid 19 Vaccine Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Covid 19 Vaccine

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Covid-19 and Influenza Oral Vaccine Study
Phase 1 · 1 location(s) · Vaxine Pty Ltd · NCT06355232Thymalfasin (Thymosin Alpha 1; Ta1) as an Enhancer of Vaccine Response Among Older Adults Receiving Booster Doses of COV
Phase 1 · 1 location(s) · The Methodist Hospital Research Institute · NCT06821100Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients
Phase N/A · 1 location(s) · University of Oxford · NCT05571735A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
Phase 4 · 6 location(s) · ModernaTX, Inc. · NCT06585241COVID-19 Impact on RSV Emergency Presentations
Phase N/A · 1 location(s) · University Hospitals, Leicester · NCT04959734Addressing Vaccine Acceptance in Carceral Settings Through Community Engagement
NA · 1 location(s) · Yale University · NCT05796505Connecting Friends and Health Workers to Boost COVID-19 Vaccination in Latino Communities
NA · 1 location(s) · Johns Hopkins University · NCT06128928Clinical Laboratory Evaluation, Assessment of Symptoms and Recovery in Patients With Post-COVID-19-Vaccination Syndrome
Phase N/A · 1 location(s) · University of Bern · NCT07400848Safety and Immunogenicity of a Sub-unit Protein CD40.RBDv Bivalent COVID-19 Vaccine, Adjuvanted or Not, as a Booster in
Phase 1/Phase 2 · 2 location(s) · ANRS, Emerging Infectious Diseases · NCT06255626COVID-19 Vaccine Effectiveness Against Recurrent Infection Among Lung Cancer Patients and Biomarker Research
NA · 1 location(s) · Peking Union Medical College Hospital · NCT06168032Safety and Serum Virus Neutralizing Antibody Responses of VYD2311, a COVID-19 Vaccine, and Coadministered VYD2311 With a
Phase 3 · 1 location(s) · Invivyd, Inc. · NCT07655180A Trial of a Next Generation COVID-19 Vaccine Delivered by Inhaled Aerosol
Phase 2 · 2 location(s) · McMaster University · NCT06381739Testimonials and Navigation in Rheumatology
NA · 3 location(s) · University of Alabama at Birmingham · NCT06469788An Experimental Medicine Multicenter Trial to Evaluate the Safety and Immunogenicity of Experimental Versus Authorized S
EARLY_Phase 1 · 3 location(s) · ANRS, Emerging Infectious Diseases · NCT07605520Immunity and Safety of Covid-19 Synthetic Minigene Vaccine
Phase 1/Phase 2 · 1 location(s) · Shenzhen Geno-Immune Medical Institute · NCT04276896Vaccine Responses to SARS-CoV-2 and Other Emerging Infectious Diseases
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT05078905Dissecting Human Immune Responses to Infection With Influenza or SARS-CoV-2
Phase N/A · 1 location(s) · Washington University School of Medicine · NCT06848309COVID-19 Vaccine-induced Inflammatory Heart Disease Prevalence Registry
Phase N/A · 1 location(s) · Ottawa Heart Institute Research Corporation · NCT05046002A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults
Phase 1 · 12 location(s) · GlaxoSmithKline · NCT07464314Study Comparing Safety and Immunogenicity of Intranasal COVID-19 Vaccine and mRNA Booster in Healthy Adults
Phase 1/Phase 2 · 5 location(s) · ANRS, Emerging Infectious Diseases · NCT06821126Understanding Immunity to the Flu Vaccine in COVID-19 Patients
Phase N/A · 1 location(s) · Stanford University · NCT04579588Genomics and COVID-19 Vaccine Adverse Events
Phase N/A · 1 location(s) · University of British Columbia · NCT05212792Safety and Immunity of Covid-19 aAPC Vaccine
Phase 1 · 1 location(s) · Shenzhen Geno-Immune Medical Institute · NCT04299724A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalati
Phase 1 · 6 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT07536308Researchers At UC San Diego Are Learning About the Benefits of Human Milk and How It Influences Infant and Child Health
Phase N/A · 1 location(s) · University of California, San Diego · NCT05553743Adjuvant Effect of Physical Exercise on Immune Response to COVID-19 Vaccination and Interactions With Stress
NA · 1 location(s) · Iowa State University · NCT05213000Impact of COVID-19 Vaccines on Cerebrovascular Health
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT04992195COVID-19 Booster and IIV Schedule in Immunocompromised Hosts
Phase 2 · 3 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT06599658A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broa
Phase 1/Phase 2 · 2 location(s) · Kara Chew · NCT06810934COVID-19 Vaccines Safety Tracking (CoVaST)
Phase N/A · 14 location(s) · Masaryk University · NCT04834869
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.